Anti-ED-A immunoconjugates for inflammatory bowel disease
US9695232B2 · kind B2 · utility
2Cited by
26References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 3, 2012 |
| Grant date | Jul 4, 2017 |
| Priority date | — |
| Expiry date | Oct 3, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/626
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Specific binding members that bind the ED-A isoform of fibronectin for use in methods of treatment, diagnosis, detection and/or imaging of inflammatory bowel disease (IBD), and/or for use in delivery to the IBD tissue of a molecule conjugated to the specific binding member. The specific binding member may, for example, be conjugated to an immunosupressive or anti-inflammatory molecule, such as interleukin-10.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.